Gene expression analyses to explore the biomarkers and therapeutic targets for gliomas

Neurological Sciences

Volumn 36, Issue 3, 2015, Pages 403-409

  Wang, Lina ^a   Wei, Bo ^a   Hu, Guozhang ^a   Wang, Le ^b   Jin, Ying ^c   Sun, Zhigang ^a,d  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c Jilin Oil Field General Hospital   (China)

^d INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

BACE1; ELAVL1; EZH2; Glioma; miR 124

Indexed keywords

BETA SECRETASE 1; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE 2; HIGH MOBILITY GROUP B3 PROTEIN; MICRORNA; MICRORNA 124; MICRORNA 200; MICRORNA 22; POLO LIKE KINASE 2; PROTEIN; PROTEIN ELAVL1; PROTEIN MBP; PROTEIN PLP1; PROTEIN WEE1; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DIVISION; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION; GENE ONTOLOGY; GLIOMA; HUMAN; MYELINATION; NERVE CELL; NUCLEOTIDE SEQUENCE; OOCYTE MATURATION; PATHOGENESIS; REGULATORY MECHANISM; SPHINGOLIPID METABOLISM; UPREGULATION; RETRACTED ARTICLE;

GENE EXPRESSION; HUMANS;

EID: 84925483477     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1985-0     Document Type: Article

References (35)

1. Mamelak AN, Jacoby DB (2007) Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Del 4(2):175–186
2. Jelsma R, Bucy PC (1967) The treatment of glioblastoma multiforme of the brain. J Neurosurg 27(5):388
3. Nakamura JL (2007) The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications. Expert Opin Ther Targets 11(4):463–472
4. Pollack IF, Hamilton RL, James CD, Finkelstein SD, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL (2006) Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children’s Cancer Group 945 cohort. J Neurosurg 105(5):418–424
5. Formosa A, Lena A, Markert E, Cortelli S, Miano R, Mauriello A, Croce N, Vandesompele J, Mestdagh P, Finazzi-Agrò E (2012) DNA methylation silences miR-132 in prostate cancer. Oncogene 32(1):127–134
6. Zhang X, Wang H, Zhang S, Song J, Zhang Y, Wei X, Feng Z (2012) MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation. Vitro Cell Dev Biol-Anim 48(2):131–136
7. Notari M, Neviani P, Santhanam R, Blaser BW, Chang J-S, Galietta A, Willis AE, Roy DC, Caligiuri MA, Marcucci G (2006) A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107(6):2507–2516
8. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin Y-L, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB (2010) TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467(7318):986–990
9. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283(2):1026–1033
10. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin G, Grazi G, Giovannini C, Croce C, Bolondi L (2008) MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27(43):5651–5661
11. Sandberg CJ, Altschuler G, Jeong J, Strømme KK, Stangeland B, Murrell W, Grasmo-Wendler U-H, Myklebost O, Helseth E, Vik-Mo EO (2013) Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt-signaling and a fingerprint associated with clinical outcome. Exp Cell Res 319(14):2230–2243
12. Fujita A, Sato JR, Rodrigues LO, Ferreira CE, Sogayar MC (2006) Evaluating different methods of microarray data normalization. BMC Bioinformatics 7(1):469
13. Gentleman R, Carey V, Huber W, Irizarry RA, Dudoit S (2005) Bioinformatics and computational biology solutions using R and Bioconductor, vol 746718470. Springer, New York
14. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289–300
15. Deza MM, Deza E (2009) Encyclopedia of distances. Springer, Heidelberg
16. Szekely GJ, Rizzo ML (2005) Hierarchical clustering via joint between-within distances: extending Ward’s minimum variance method. J Classif 22(2):151–183
17. Kraskov A, Stögbauer H, Andrzejak RG, Grassberger P (2005) Hierarchical clustering using mutual information. EPL 70(2):278
18. Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S, Kong L, Gao G, Li CY, Wei L (2011) KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acid Res 39(Suppl 2):W316–W322
19. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33(suppl 2):W741–W748
20. Duncan D, Prodduturi N, Zhang B (2010) WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics 11(Suppl 4):P10
21. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39(suppl 1):D561–D568
22. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27(3):431–432
23. Maere S, Heymans K, Kuiper M (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21(16):3448–3449
24. Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205(12):613–621
25. Reuss D, von Deimling A (2009) Hereditary tumor syndromes and gliomas. In: Gliomas, vol 171. Springer, pp 83–102
26. Makeyev EV, Zhang J, Carrasco MA, Maniatis T (2007) The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27(3):435–448
27. Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T (2006) The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580(8):2011–2014
28. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419(6907):624–629
29. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, Kha H, Zhang J, Gong Y (2001) Mice deficient in BACE1, the Alzheimer’s β-secretase, have normal phenotype and abolished β-amyloid generation. Nat Neurosci 4(3):231–232
30. Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, Inagawa K, Kawakami Y, Yoshida K, Toda M (2012) Downregulation of KIF23 suppresses glioma proliferation. J Neurooncol 106(3):519–529
31. Lundgren K, Walworth N, Booher R, Dembski M, Kirschner M, Beach D (1991) mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell 64(6):1111–1122
32. Gubanova E, Issaeva N, Gokturk C, Djureinovic T, Helleday T (2013) SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways. Cell Cycle 12(24):3770–3780
33. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349(6311):704–706
34. Inoue K (2005) PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6(1):1–16
35. Taylor IA, McIntosh PB, Pala P, Treiber MK, Howell S, Lane AN, Smerdon SJ (2000) Characterization of the DNA-binding domains from the yeast cell-cycle transcription factors Mbp1 and Swi4. Biochemistry 39(14):3943–3954